Skip to main navigation Skip to search Skip to main content

Liver Transplantation in Mixed Hepatocellular Carcinoma and Cholangiocarcinoma

Research output: Contribution to journalReview articlepeer-review

Abstract

Mixed hepatocellular carcinoma and cholangiocarcinoma (HCC-CC) are rare tumors, and the risk factors associated with them are not well understood yet. Moreover, the diagnosis of mixed HCC-CC can be complicated due to the difficulty in distinguishing mixed HCC-CC from HCC and intrahepatic CCC on radiological images. Serum tumor markers are useful when the radiological images are inconclusive. It remains unclear whether the prognosis of mixed HCC-CC differs from that of HCC. However, several studies have reported that the tumor recurrence and patient survival rates of mixed HCC-CC were similar to those of HCC after liver transplantation (LT) and liver resection. In this paper, we report that LT in patients with mixed HCC-CC achieves outcomes which are similar to those seen in LT for HCC. Therefore, the diagnosis of mixed HCC-CC should not be considered as a contraindication for LT.

Original languageEnglish
Pages (from-to)85-90
Number of pages6
JournalJournal of Liver Cancer
Volume19
Issue number2
DOIs
StatePublished - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Liver malignancy
  • Liver transplantation
  • Outcomes

Fingerprint

Dive into the research topics of 'Liver Transplantation in Mixed Hepatocellular Carcinoma and Cholangiocarcinoma'. Together they form a unique fingerprint.

Cite this